mylan ceo to depart as part of deal with pfizer's off-patent drug business
Published 5 years ago • 768 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
2:50
pfizer to combine off-patent drug business with mylan
-
4:42
pfizer to merge off-patent drug business with mylan
-
3:58
mylan meets with investors to communicate benefits of pfizer merger
-
2:34
pfizer to merge off-patent unit with mylan in all-stock deal
-
3:06
mylan, pfizer combined could generate more than $19 billion in annual sales: analyst
-
3:05
mylan ceo: epipen $608 price was 'fair'
-
2:54
biden administration announces 10 drugs targeted for medicare price negotiation
-
19:35
pfizer ceo on sales, m&a, mrna, weight loss drug
-
5:48
jefferies' holz: pfizer, mylan deal not seen as defensive, both business in 'tight spaces'
-
2:31
health-care m&a takes center stage with mylan-pfizer, exact-genomic deals
-
2:28
big pharma deal between pfizer & mylan
-
1:33
pfizer, u.s. nears deal to deliver 100m more covid-19 vaccines
-
4:52
pharmaceutical companies losing patent protection as competition grows
-
2:45
phizer buys mylan after stock drop
-
1:44
pfizer ceo sold $5.6 million worth of stock amid the pandemic
-
2:32
mylan planning strategic review of its business
-
3:59
time to buy mylan? when will energy rebound? and more in #askhalftime
-
4:13
pfizer to provide patent-protected medicines at cost in low-income countries
-
1:44
pfizer announces plans to reorganize into three internal units
-
1:47
pfizer ceo: made decision to defer drug prices after trump tweet
-
4:54
pfizer ceo sold $5.6 million stock in pre-planned sale on day of vaccine news release
-
0:19
pfizer to absorb mylan, creating generic giant